Kisspeptin-10 vs Leuprolide

Kisspeptin acts upstream, triggering GnRH neurons. Leuprolide acts at the pituitary and, given continuously, shuts down LH and FSH release.

HPLC tested · JanoshikJanoshik CertificatesNationwide DeliveryResearch Only

🧪

Kisspeptin-10

The shortest active fragment of kisspeptin, the hypothalamic peptide that triggers GnRH release and sits at the top of the reproductive axis.

BEST STUDIED FOR

Reproductive axis

Read the cited profile →

🧪

Leuprolide

A GnRH-agonist peptide that first stimulates, then shuts down, the reproductive axis — "medical castration" used in prostate cancer and other hormone-driven conditions.

BEST STUDIED FOR

Reproductive axis

Read the cited profile →

SIDE BY SIDE

	Kisspeptin-10	Leuprolide
The key difference	Stimulates GnRH release	Suppresses the axis with continuous use
Class	Reproductive axis	Reproductive axis
Mechanism	Kisspeptin binds its receptor (KISS1R/GPR54) on GnRH neurons, driving GnRH pulses and therefore LH, FSH and testosterone/oestrogen.	Continuous exposure to a potent GnRH agonist desensitises pituitary GnRH receptors: after an initial LH/testosterone flare, gonadal steroid production is suppressed.
Status	Human research tool in reproductive endocrinology (fertility, hypothalamic amenorrhoea); not an approved medicine.	Registered medicine (prostate cancer, endometriosis, central precocious puberty; also approved in Japan for spinal and bulbar muscular atrophy).
Reported safety signals	Short-term human studies are physiological; repeated exposure can desensitise the axis in some protocols. A 2024 study also found KISS1R signalling in osteoclasts.	Effects follow from sex-steroid suppression (hot flushes, bone loss); the initial flare is a recognised issue.
A key study	Reviews kisspeptin as the critical central regulator of GnRH release. (Front Endocrinol (Lausanne) 2022, PMID 35837314)	Reviews leuprorelin as a GnRH analogue used across sex-hormone-related disorders. (Drugs 1994, PMID 7533699)

WHEN TO RESEARCH WHICH

Kisspeptin for stimulation and fertility research; leuprolide for suppression. Both are discussed here strictly as research compounds; nothing on this page is medical advice or a dosing guide.

REFERENCES (PUBMED)

[Kisspeptin-10] The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction — Front Endocrinol (Lausanne) 2022. PMID 35837314
[Kisspeptin-10] Metabolic regulation of kisspeptin - the link between energy balance and reproduction — Nat Rev Endocrinol 2020. PMID 32427949
[Kisspeptin-10] Kisspeptin and neurokinin B: roles in reproductive health — Physiol Rev 2025. PMID 39813600
[Leuprolide] Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders — Drugs 1994. PMID 7533699
[Leuprolide] Clinical pharmacokinetics of depot leuprorelin — Clin Pharmacokinet 2002. PMID 12083977
[Leuprolide] The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysis — Adv Ther 2025. PMID 40498278

FREQUENTLY ASKED

What is the difference between Kisspeptin-10 and Leuprolide?

Kisspeptin acts upstream, triggering GnRH neurons. Leuprolide acts at the pituitary and, given continuously, shuts down LH and FSH release.

What is the regulatory status of Kisspeptin-10 and Leuprolide?

Kisspeptin-10: Human research tool in reproductive endocrinology (fertility, hypothalamic amenorrhoea); not an approved medicine. Leuprolide: Registered medicine (prostate cancer, endometriosis, central precocious puberty; also approved in Japan for spinal and bulbar muscular atrophy).

What safety signals have been reported?

Kisspeptin-10: Short-term human studies are physiological; repeated exposure can desensitise the axis in some protocols. A 2024 study also found KISS1R signalling in osteoclasts. Leuprolide: Effects follow from sex-steroid suppression (hot flushes, bone loss); the initial flare is a recognised issue.

Which studies is this comparison based on?

For Kisspeptin-10: “The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction” (PMID 35837314); “Metabolic regulation of kisspeptin - the link between energy balance and reproduction” (PMID 32427949); “Kisspeptin and neurokinin B: roles in reproductive health” (PMID 39813600). For Leuprolide: “Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders” (PMID 7533699); “Clinical pharmacokinetics of depot leuprorelin” (PMID 12083977); “The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysis” (PMID 40498278).